Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
They are regulated pharmaceutical interventions that require a prescription, ongoing medical supervision, and carry meaningful side effect profiles that differ significantly from person to person
Your doctor will likely monitor the following: Blood glucose levels: If you have type 2 diabetes, your doctor will check your average blood sugar levels through a test called an A1C
The methyltransferase DOT1L controls activation and lineage integrity in CD4 + T cells during infection and inflammation
They do not claim to affect GLP-1 levels
Packaging includes tamper-evident seals and should come in the original manufacturer's blister packs, not loose or repackaged